Olivo Alicia C (CIK 1951869) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Buy NEO (3,944 shares), Sell NEO (2,559 shares), Buy NEO (21,079 shares), Sell NEO (8,295 shares), Buy NEO (8,443 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 3,944 | $0 |
| 2026-05-13 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 2,559 | $0 |
| 2026-02-24 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 21,079 | $0 |
| 2026-02-24 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 8,295 | $0 |
| 2026-02-24 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 8,443 | $0 |
| 2026-02-24 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 3,323 | $0 |
| 2026-01-15 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 59,382 | $0 |
| 2026-01-15 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 15,145 | $0 |
| 2025-11-28 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 8,977 | $90,219 |
| 2025-11-28 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 20,916 | $250,992 |
| 2025-10-20 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 4,918 | $49,180 |
| 2025-09-03 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 1,666 | $0 |
| 2025-08-05 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 14 | $0 |
| 2025-05-13 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 6,503 | $0 |
| 2025-05-13 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 1,584 | $0 |
| 2025-05-05 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 652 | $0 |
| 2025-02-25 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Buy | 8,443 | $0 |
| 2025-02-25 | NEOGENOMICS INC (NEO) | EVP, GC & Business Development | Sell | 2,504 | $0 |
Source: SEC Form 4 filings · as of 2026-05-13